1. 278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer. (10th December 2020) Authors: Blumenschein, George; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin; Heymach, John; Govindan, Ramaswamy; Bachier, Carlos; Spéville, Bernard Doger de; Frigault, Matthew; Olszanski, Anthony; Lam, Vincent; Hyland, Natalie; Navenot, Jean-Marc; Fayngerts, S... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer. (9th November 2020) Authors: Blumenschein, George; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin; Heymach, John; Govindan, Ramaswamy; Bachier, Carlos; Spéville, Bernard Doger de; Frigault, Matthew; Olszanski, Anthony; Lam, Vincent; Hyland, Natalie; Navenot, Jean-Marc; Fayngerts, S... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results. (9th November 2020) Authors: Borghaei, Hossein; Boyer, Michael; Johnson, Melissa; Govindan, Ramaswamy; Rodrigues, Luis Paz-Ares; Blackhall, Fiona; Boosman, Rene; Champiat, Stéphane; Hummel, Horst-Dieter; Victoria Lai, W; Udagawa, Hibiki; Chiang, Anne; Dowlati, Afshin; Hann, Christine; Salgia, Ravi; Vokes, Everett; Minocha, M... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results. (9th November 2020) Authors: Borghaei, Hossein; Boyer, Michael; Johnson, Melissa; Govindan, Ramaswamy; Rodrigues, Luis Paz-Ares; Blackhall, Fiona; Boosman, Rene; Champiat, Stéphane; Hummel, Horst-Dieter; Victoria Lai, W; Udagawa, Hibiki; Chiang, Anne; Dowlati, Afshin; Hann, Christine; Salgia, Ravi; Vokes, Everett; Minocha, M... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 364 A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first line, non-squamous NSCLC. (10th December 2020) Authors: Awad, Mark; Spigel, David; Garon, Edward; Waqar, Saiama; Lisberg, Aaron; Moles, Melissa; Tepper, Jennifer; Lamb, April; Wanamaker, Amy; Khondker, Zakaria; Srouji, John; Dong, Jesse; Poran, Asaf; Balogh, Kristen; Bushway, Meghan; DeMario, Mark; Srinivasan, Lakshmi; Gaynor, Richard; Govindan, Ramas... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 802 Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint blockade. (9th November 2020) Authors: Herzog, Brett; Waqar, Saiama; Devarakonda, Siddhartha; Ward, Jeffrey; Govindan, Ramaswamy; Morgensztern, Daniel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data. (December 2018) Authors: Ainscough, Benjamin; Barnell, Erica; Ronning, Peter; Campbell, Katie; Wagner, Alex; Fehniger, Todd; Dunn, Gavin; Uppaluri, Ravindra; Govindan, Ramaswamy; Rohan, Thomas; Griffith, Malachi; Mardis, Elaine; Swamidass, S.; Griffith, Obi Journal: Nature genetics Issue: Volume 50:Number 12(2018) Page Start: 1735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies. (1st July 2022) Authors: Fracasso, Paula M.; Goodner, Sherry A.; Wildi, Jonathan D.; Naughton, Michael J.; Linette, Gerald P.; Govindan, Ramaswamy; Tan, Benjamin R.; Blum, Kristie A.; Jones, Gary J.; Pearce, Tillman E.; Levitt, Daniel J.; Clamon, Gerald H. Journal: American journal of clinical oncology Issue: Volume 45:Number 7(2022) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC). Issue 24 (1st November 2018) Authors: Morgensztern, Daniel; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E.; Lewanski, Conrad R.; Bennouna, Jaafar; Fischer, Jürgen R.; Juan‐Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C.; Jin Ong, Teng; Govindan, Ramas... Journal: Cancer Issue: Volume 124:Issue 24(2018) Page Start: 4667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Accounting for proximal variants improves neoantigen prediction. (January 2019) Authors: Hundal, Jasreet; Kiwala, Susanna; Feng, Yang-Yang; Liu, Connor; Govindan, Ramaswamy; Chapman, William; Uppaluri, Ravindra; Swamidass, S.; Griffith, Obi; Mardis, Elaine; Griffith, Malachi Journal: Nature genetics Issue: Volume 51:Number 1(2019) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗